Drug Search Results
More Filters [+]

Indapamide

Alternative Names: indapamide, lozol
Latest Update: 2024-10-30
Latest Update Note: Clinical Trial Update

Product Description

Indapamide, a 'water pill,' is used to reduce the swelling and fluid retention caused by heart disease. It also is used to treat high blood pressure. It causes the kidneys to get rid of unneeded water and salt from the body into the urine. (Sourced from: https://medlineplus.gov/druginfo/meds/a684062.html)

Mechanisms of Action: Potassium Channel Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: George Institute for Global Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Indapamide

Countries in Clinic: Australia, China, Czech Republic, Korea, New Zealand, Nigeria, Poland, Russia, Sri Lanka, United Kingdom, United States

Active Clinical Trial Count: 14

Highest Development Phases

Phase 3: Hypertension|Stroke

Phase 1: Acute Respiratory Distress Syndrome

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2020-004891-16

P3

Active, not recruiting

Hypertension

2024-12-29

BR-FIC-CT-301

P3

Recruiting

Hypertension

2024-10-01

90%

BR-FIC-CT-301

P3

Recruiting

Hypertension

2024-10-01

90%

BR-FIC-CT-301

P3

Recruiting

Hypertension

2024-10-01

90%

TRIDENT

P3

Recruiting

Stroke|Hypertension

2024-09-30

TRIDENT

P3

Active, not recruiting

Hypertension|Stroke

2023-12-28

Recent News Events